Bromocriptine therapy in chronic schizophrenia: Effects on symptomatology, sleep patterns, and prolactin response to stimulation
- 1 March 1983
- journal article
- research article
- Published by Elsevier in Psychiatry Research
- Vol. 8 (3) , 159-169
- https://doi.org/10.1016/0165-1781(83)90059-8
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Suppression of REM and delta sleep by apomorphine in man: A dopamine mimetic effectPsychopharmacology, 1980
- Dopamine receptor sensitivity in the hypothalamus of chronic schizophrenics after haloperidol therapy: Growth hormone and prolactin response to stimuliPsychoneuroendocrinology, 1979
- Catecholaminergic Drugs in Chronic SchizophreniaNeuropsychobiology, 1979
- Paradoxical reaction to L-dopa in schizophrenic patientsAmerican Journal of Psychiatry, 1978
- Bromocriptine, dihydroergotoxine, methysergide, d-LSD, CF 25-397, and 29-712: Effects on the metabolism of the biogenic amines in the brain of the ratPsychopharmacology, 1978
- Restatement and Prospectives of Ergot Alkaloids in Clinical Neurology and PsychiatryPharmacology, 1978
- Receptor sensitivity modification (RSM) — A new paradigm for the potential treatment of some hormonal and transmitter disturbancesComprehensive Psychiatry, 1977
- Letter: Treatment of mania with bromocriptine.BMJ, 1976
- Behavioral effects of l-Dopa in schizophrenic patientsPsychopharmacology, 1973
- LEVODOPA IN DRUG-INDUCED EXTRAPYRAMIDAL DISORDERSThe Lancet, 1970